Add BrightSurf on Google Email

Study finds regular aspirin use associated with greatest reduction in colorectal cancer among those most at risk

A study published in JAMA Oncology found that regular aspirin use significantly lowers the risk of colorectal cancer in individuals with higher lifestyle-related risk factors. The benefits were most pronounced among those with unhealthiest lifestyles, where treating 78 patients with aspirin would prevent one case of colorectal cancer o...

SourceMass General Brigham·JournalJAMA Oncology·TypeObservational study·DateAug 1, 2024

Cleveland Clinic-led research identifies priority zones that may help improve colorectal cancer screening among Hispanic/Latino individuals

Researchers identified areas with lower colorectal cancer screening rates and developed an interactive web map to pinpoint neighborhood-level disparities. The study aims to inform targeted education or intervention programs, ultimately increasing screening rates in priority neighborhoods and contributing to national improvements.

SourceCleveland Clinic·JournalAmerican Journal of Public Health·DateJul 31, 2024

Liver transplant outperforms other therapies for colorectal cancer that has spread to the liver

A study published in JAMA Surgery shows that liver transplants significantly improve progression-free survival rates for patients with unresectable colorectal liver metastases compared to other therapies. At three years, 90% of transplant patients remained cancer-progression free, whereas only 42% of those receiving alternative treatme...

SourceUniversity of Rochester Medical Center·JournalJAMA Surgery·TypeObservational study·DateJul 30, 2024

New study shows at-home colon cancer screening test reduces risk of colorectal cancer death, as effective as screening colonoscopy

A new study published in JAMA Network Open shows that an at-home fecal immunochemical testing (FIT) screen can reduce the risk of colorectal cancer death by 33%, comparable to screening colonoscopy. FIT is a non-invasive test that involves mailing a stool sample to the laboratory for analysis.

SourceOhio State University Wexner Medical Center·JournalJAMA·TypeData/statistical analysis·DateJul 25, 2024

Preventing cancer cells from colonizing the liver

Cancer cells can attach themselves to liver cells when specific proteins are present, allowing them to colonize and form new tumors. This discovery provides insights into the metastatic process and may lead to potential treatments that prevent cancer from establishing new tumors.

SourceETH Zurich·JournalNature·TypeExperimental study·DateJul 24, 2024

How to eliminate racial disparities in colon cancer

Researchers found that eliminating racial disparities in follow-up colonoscopy rates and quality would significantly reduce colorectal cancer incidence and mortality. By closing these gaps, the study aims to achieve health equity and find innovative solutions for true change.

SourceOxford University Press USA·JournalJNCI Journal of the National Cancer Institute·TypeData/statistical analysis·DateJul 24, 2024

A new biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

Researchers have identified a potential biomarker, CXCL13, that correlates with treatment response and prognosis in patients with metastatic colorectal cancer. High levels of CXCL13 are associated with positive treatment response and improved survival, while low levels indicate non-response and poorer prognosis.

SourceGermans Trias i Pujol Research Institute·JournalBiomedicine & Pharmacotherapy·TypeExperimental study·DateJul 15, 2024

Immunotherapy in colorectal cancer

Immunotherapy has emerged as a promising approach in treating metastatic colorectal cancer, especially for patients with dMMR/MSI-H tumors. The use of immune checkpoint inhibitors has shown favorable outcomes in clinical trials, including improved progression-free survival and disease control rates.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateJul 1, 2024

AI-based Alphafold: Its potential impact on predictive medicine

AlphaFold's groundbreaking ability to predict protein structures is set to transform predictive medicine, enabling the development of personalized vaccines and adaptive clinical trials. However, the review also highlights crucial challenges and ethical considerations surrounding AI integration with clinical data.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalAI in Precision Oncology·TypeLiterature review·DateJun 26, 2024

Promising role of antidiabetic drug in cancer control

Researchers found that metformin increases levels of microRNAs miR-2110 and miR-132-3p, targeting genes PIK3R3 and STMN1 to slow down cancer cell growth and division. This study provides new insights into metformin's molecular mechanisms and its potential as a preventive agent for reducing cancer growth.

SourceFlinders University·JournalCancers·TypeExperimental study·DateJun 11, 2024

Trust and acceptance among gastroenterologists for AI to be used in clinics and hospitals, finds NTU Singapore study

A recent NTU Singapore study found that eight in ten gastroenterologists accept and trust the use of AI-powered tools in diagnosing and assessing colorectal polyps. The study, which surveyed 165 doctors in the Asia-Pacific region, also found that more experienced gastroenterologists perceived a lower risk of AI tools.

SourceNanyang Technological University·JournalJournal of Controlled Release·DateJun 6, 2024

Lowering fecal immunochemical test positivity threshold vs multitarget stool RNA testing for colorectal cancer screening

This study found that lowering the fecal immunochemical test positivity threshold can achieve comparable sensitivity and specificity to the multitarget stool RNA test without additional testing. The findings are similar to previous observations with multitarget stool DNA testing, suggesting a potentially simpler screening method.

SourceJAMA Network·JournalJAMA·DateJun 1, 2024

ASCO: Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer

A study by UCLA Health Jonsson Comprehensive Cancer Center researchers found that combining experimental immunotherapy drugs with chemotherapy significantly improves progression-free survival and overall survival for patients with metastatic colorectal cancer. The median progression-free survival was 6.2 months compared to 2.1 months f...

Colorectal cancer: Tracking down subtypes

A meta-analysis suggests combining microsatellite instability (MSI) and tumor-infiltrating lymphocytes (TIL) can optimize prognostic assessment in early-stage colorectal cancer. Patients with high MSI and TIL had the best prognosis, while those with low immune cells found in the tumor tissue had a poor outcome.

SourceGerman Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)·JournalThe Lancet Gastroenterology & Hepatology·TypeMeta-analysis·DateMay 16, 2024

Offering both colonoscopy and at-home tests doubled colorectal cancer screening

A study led by the University of Pennsylvania School of Medicine found that offering patients a choice between colonoscopy and at-home tests more than doubled colorectal cancer screening rates. Approximately 10% of participants received colonoscopies, while around 11% completed at-home fecal immunochemical tests.

SourceUniversity of Pennsylvania School of Medicine·JournalClinical Gastroenterology and Hepatology·TypeRandomized controlled/clinical trial·DateMay 16, 2024

Affordable Care Act expansions improved access to cancer care, study suggests

A study published by University of Pittsburgh researchers found that ACA insurance expansions led to an increase in patients receiving care at accredited cancer hospitals in Pennsylvania. The study suggests that these expansions make a difference in improving access to high-quality cancer care, particularly for those living in areas wi...

SourceUniversity of Pittsburgh·JournalHealth Services Research·TypeData/statistical analysis·DateMay 3, 2024

Innovative primary care program blending virtual with in-person options connects locals to family physicians

The innovative Integrated Virtual Care (IVC) program successfully connected residents with family physicians in Renfrew County, addressing the rural shortage of primary care providers. Over 2,800 unique patient appointments were conducted, with 70% done virtually, offering comprehensive team-based primary care.

SourceUniversity of Ottawa·JournalCanadian Journal of Rural Medicine·TypeMeta-analysis·DateApr 18, 2024

Study shows improved outcomes in hospitals accredited for rectal cancer surgery

A study published in the Journal of the American College of Surgeons found that hospitals accredited by the National Accreditation Program for Rectal Cancer (NAPRC) demonstrate significantly better outcomes for patients undergoing rectal cancer surgery. These institutions show lower rates of mortality, complications, and morbidity comp...

SourceAmerican College of Surgeons·JournalJournal of the American College of Surgeons·DateMar 28, 2024

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

Researchers have found that combining DNMT and EZH2 inhibitors activates viral mimicry in cancer cells, making them more susceptible to attack by the immune system. The combination therapy has shown potential in treating colorectal cancers and other solid tumors, with an upcoming Phase I clinical trial planned.

SourceVan Andel Research Institute·JournalScience Advances·TypeExperimental study·DateMar 27, 2024

New data offer reality check on blood-based colorectal cancer screening

New data suggest that blood-based colorectal cancer screening tests could lead to more cases and deaths than established methods, despite improving outcomes for unscreened individuals. The tests are predicted to be less effective and more costly, making them unsuitable replacements for current screening programs.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·TypeCommentary/editorial·DateMar 26, 2024

Bacteria subtype linked to growth in up to 50% of human colorectal cancers, Fred Hutch researchers report

Researchers at Fred Hutchinson Cancer Center found that a specific subtype of Fusobacterium nucleatum is responsible for tumor growth in up to 50% of human colorectal cancers. The study identifies the exact bacterial lineage associated with colorectal cancer, offering opportunities for developing microbial cellular therapies.

SourceFred Hutchinson Cancer Center·JournalNature·TypeObservational study·DateMar 20, 2024

Colorectal cancer screening in Araba (Basque Country)

The study found that 90.98% of participants obtained a definitive result from colorectal cancer screening, with 31.71% being normal and 5.49% having non-neoplastic polyps. The results suggest the importance of primary care physicians in promoting secondary prevention and informing the population about the program.

SourceXia & He Publishing Inc.·JournalCancer Screening and Prevention·DateMar 19, 2024

U.S. could cut cervical cancer cases & deaths by up to 20% if more patients got follow-up after screening, study suggests

A new study suggests that removing barriers to cervical cancer screening, surveillance, and diagnostic procedures can save lives and reduce disparities. If every eligible person gets the full screening and follow-up tests recommended, up to 23% fewer people would be diagnosed with cervical cancer and 20% fewer would die from it.

SourceMichigan Medicine - University of Michigan·TypeData/statistical analysis·DateMar 19, 2024

Newly discovered link between FBXW7 mutations and EGFR signaling in colorectal cancer

A new link has been discovered between FBXW7 mutations and EGFR signaling activity in colorectal cancer. The study found that the mutated form of the FBXW7 gene could no longer degrade the EGFR protein, leading to increased signaling activity and a decreased response to anti-EGFR treatment.

SourceHubrecht Institute·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 18, 2024

New research in April: colorectal cancer, kidney health, OR supply costs, and more

Research highlights new findings on social vulnerability and survivorship after colorectal cancer resection, as well as disparities in kidney recovery among Black donors. Additionally, studies reveal cost savings from implementing quality interventions and explore eligibility for transplants in obese patients with end-stage renal disease.

SourceAmerican College of Surgeons·JournalJournal of the American College of Surgeons·DateMar 15, 2024